Company news: Par Pharmaceutical; Gilead

Matthew Arnold

July 16 2012

Par Pharmaceutical is going private, selling to TPG for $1.9 billion in cash.

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.